IMPACT OF PRE-TREATMENT PLASMA HBV DNA LEVELS ON THE RATE OF ALT NORMALIZATION DURING ANTIVIRAL THERAPY WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR CHRONIC HEPATITIS B (CHB)
单位：[1]Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea[2]Liver Center, Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea[3]Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine[4]Dept. of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy[5]Department of Infectious Diseases, Nanfang Hospital, Southern Medical University[6]Institute of Liver Studies, King’s College Hospital[7]Clinical Task Force, National Hepatitis C Program Office, Ministry of Health and Welfare[8]Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, China华中科技大学同济医学院附属同济医院[9]National University Hospital Singapore[10]National Institute for Infectious Diseases, Carol Davila University of Medicine and Pharmacy, Romania[11]Gilead Sciences, Inc.[12]Gilead Sciences, Inc., Foster City, CA, USA[13]Heritage Medical Research Clinic[14]Liver Unit, Internal Medicine Department. Hospital Universitari Vall d’Hebron, Barcelona, Spain, University Hospital Vall D’hebron[15]The Chinese University of Hong Kong, Hong Kong, China
第一作者单位：[1]Department of Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
推荐引用方式(GB/T 7714)：
Young-Suk Lim,Jonggi Choi,Won-Mook Choi,et al.IMPACT OF PRE-TREATMENT PLASMA HBV DNA LEVELS ON THE RATE OF ALT NORMALIZATION DURING ANTIVIRAL THERAPY WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR CHRONIC HEPATITIS B (CHB)[J].HEPATOLOGY.2020,72:485A-485A.
APA：
Young-Suk Lim,Jonggi Choi,Won-Mook Choi,Maurizia R. Brunetto,JinLin Hou...&Henry Lik Yuen Chan.(2020).IMPACT OF PRE-TREATMENT PLASMA HBV DNA LEVELS ON THE RATE OF ALT NORMALIZATION DURING ANTIVIRAL THERAPY WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR CHRONIC HEPATITIS B (CHB).HEPATOLOGY,72,
MLA：
Young-Suk Lim,et al."IMPACT OF PRE-TREATMENT PLASMA HBV DNA LEVELS ON THE RATE OF ALT NORMALIZATION DURING ANTIVIRAL THERAPY WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) FOR CHRONIC HEPATITIS B (CHB)".HEPATOLOGY 72.(2020):485A-485A
医学